Everest Organics Limited reported a net profit of ₹262.93 lakh for the quarter ended March 31, 2026, a significant increase from the ₹35.63 lakh recorded in the quarter ended December 31, 2025. Total revenue from operations for the quarter rose to ₹4,874.62 lakh, compared to ₹4,259.41 lakh in the previous quarter. For the full financial year, the company achieved a total revenue of ₹19,615.77 lakh and a net profit of ₹291.30 lakh for the period after tax and exceptional items.

The company's Board of Directors approved the audited financial results during a meeting held on May 29, 2026. The results were reviewed by the Audit Committee and are subject to an audit report by the statutory auditors. Everest Organics filed these results with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Summary

The financial statements indicate a strong performance in the final quarter of the fiscal year. The basic and diluted earnings per share (EPS) for the quarter ended March 31, 2026, stood at ₹2.69, up from ₹0.37 in the prior quarter. For the year ended March 31, 2026, the basic and diluted EPS were reported at ₹5.70.

Operational Highlights

Equity share capital remained constant at ₹971.05 lakh throughout the reported periods. Other equity, excluding revaluation reserve, was reported at ₹6,576.77 lakh for the quarter ended March 31, 2026, compared to ₹6,315.37 lakh in the previous quarter. The company operates as an ISO 9001:2015 and WHO GMP certified entity.

Everest Organics Limited has informed the stock exchanges that its board of directors will meet on Friday, May 29, 2026. The meeting has been convened pursuant to Regulations 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for the Meeting

The primary agenda for the upcoming board meeting includes the consideration and approval of the audited standalone financial results of the company for the quarter and year ended March 31, 2026. Additionally, the directors will take note of the draft report of the statutory auditors for the financial year ending March 31, 2026.

Trading Window Closure

In accordance with regulatory requirements, the company had previously intimated that the trading window closure period commenced on April 01, 2026. This window shall remain closed until 48 hours after the declaration of the audited standalone financial results for the quarter and year ended March 31, 2026.

Key Meeting Details

The intimation regarding this board meeting is available on the company's official website and the website of the stock exchange where its shares are listed.